Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman.

Passamonti, Francesco; Rumi, Elisa; Malabarba, Lucia; Arcaini, Luca; Orlandi, Ester; Brusamolino, Ercole; Pascutto, Cristiana; Cazzola, Mario; Lazzarino, Mario

Passamonti, Francesco; Rumi, Elisa; Malabarba, Lucia; Arcaini, Luca; Orlandi, Ester; Brusamolino, Ercole; Pascutto, Cristiana; Cazzola, Mario; Lazzarino, Mario.

Affiliation

Passamonti F; Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Viale Golgi 19, Pavia, Italy. f.passamonti@smatteo.pv.it

Ann Hematol ; 83(8): 495-7, 2004 Aug.

Article in En | MEDLINE | ID: mdl-15175894

Subject(s)

Pipobroman/administration & dosage; Thrombocythemia, Essential/drug therapy; Thrombocythemia, Essential/mortality; Adult; Cause of Death; Drug Evaluation; Female; Humans; Incidence; Leukemia/etiology; Leukemia/prevention & control; Longitudinal Studies; Male; Middle Aged; Remission Induction; Survival Analysis; Thrombocythemia, Essential/complications; Thrombosis/etiology; Thrombosis/prevention & control

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Pipobroman / Thrombocythemia, Essential Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2004 Type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links